Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)
2013 · British Journal of Cancer · 105 citations
https://doi.org/10.1038/bjc.2013.119
Pfizer (Sweden)(SE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
283
Citations
8
h-index
7
i10-index
Thomas Wahlgren is an academic researcher from Pfizer (Sweden). The author has contributed to research in topics: Renal cell carcinoma treatment & Prostate Cancer Diagnosis and Treatment & Economic and Financial Impacts of Cancer. The author has an h-index of 8, co-authored 13 publications.
ORCID: 0000-0003-1403-9304Click to start Chat